Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zolbetuximab + mFOLFOX6/CAPOX in CLDN18.2+ Advanced Biliary Tract Cancers
NCT07723534Phase 2Not yet recruiting
- Start
- Nov 2026
- Primary completion
- Feb 2029
- Countries
- 1
01
Overview
A Phase 2 trial of zolbetuximab in biliary tract cancer (BTC). Planned start Nov 2026; status: not yet recruiting.
02
Drugs
zolbetuximab
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT07723534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07723534.